AUROBINDO PHARMA Share price, NSE/BSE Forecast News and Quotes| Equitymaster
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Share Price   (AUBD)

Here is the latest stock price and chart of Aurobindo Pharma. For more details, see the Aurobindo Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Oct 23, 2018 (Close)
Price (Rs)738.30 Open (Rs) 750.00 High (Rs) 758.50 Low (Rs) 735.00
% Change-2.44 Volume 135,633 Value (Rs) 100,783,506 52-Week H/L 826.35 / 527.05
Live NSE Quotes Oct 23, 2018 (Close)
Price (Rs)738.85 Open (Rs) 754.90 High (Rs) 759.00 Low (Rs) 736.00
% Change-2.65 Volume 2,177,417 Value (Rs) 1,628,723,271 52-Week H/L 827.45 / 527.00
Valuation
EPS (Rs)* 40.31 P/E Ratio (x) 18.32 Market Cap (Rs m) 432,030.27 P/BV (x) 3.70
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

AUROBINDO PHARMA Share Price Today:

AUROBINDO PHARMA last traded price was down 2.4% to Rs 738.3 on the BSE. On the NSE, AUROBINDO PHARMA last traded price was down 2.7% to Rs 738.9. The total volume of shares traded was 2.3 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 2.3%. And the benchmark S&P BSE SENSEX was at 33,847.2 (down 0.8%).

Over the last 30 days, the AUROBINDO PHARMA share price is up 1.1%. And over the last one year, AUROBINDO PHARMA share price is down 1.6%.





Today's Market

Sensex Ends Over 280 Points Lower; IT and Healthcare Stocks Witness Selling(Closing)

After trading on a negative note throughout the day, share markets in India continued their downtrend during the closing hours and ended the day in red.

Related Views On News

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Oct 3, 2018 | Updated on Oct 3, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 12.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, AUROBINDO PHARMA has posted a net profit of Rs 5 bn (down 12.0% YoY). Sales on the other hand came in at Rs 43 bn (up 15.5% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 0.4% (Quarterly Result Update)

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, AUROBINDO PHARMA has posted a net profit of Rs 5 bn (down 0.4% YoY). Sales on the other hand came in at Rs 40 bn (up 11.2% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

You Can Buy Select Auto Stocks Now for Big Long-Term Returns(The 5 Minute Wrapup)

Oct 17, 2018

Irrespective of the earnings hiccups, these businesses be setting new profit records.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Stop! Read This Before You Cancel Your SIPs(Profit Hunter)

Oct 11, 2018

Read this before you stop your SIP's in equity mutual funds.

Even If IL&FS Group Brought This Correction, this is Right Time to Buy & Sit Tight!(Chart Of The Day)

Oct 12, 2018

Even if IL&FS is the culprit, it may turn out to be a hero if you buy right and sit tight.

Why Oil Cannot Be Sold to India in Rupees(Vivek Kaul's Diary)

Oct 16, 2018

Oil is bought and sold internationally in terms of dollars. And any change to this, will be attacking the exorbitant privilege of the US dollar.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - CIPLA COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS